Flow Diverters Market, by Type (Pipeline embolization device, Silk flow diverter, Surpass flow diverter, Flow redirection endoluminal device, Others), by Application (Cerebral aneurysms, Multiple Intracranial Aneurysms, Others), by End User (Hospital and clinics, Ambulatory surgical center): Global Opportunity Analysis and Industry Forecast, 2021-2031

Flow Diverters Market Research, 2031

The global flow diverters market size was valued at $251.50 million in 2021, and is projected to reach $1,041.90 million by 2031, growing at a CAGR of 15.3% from 2022 to 2031. An inappropriate focal dilatation of an artery in the brain caused by a weakening of the inner muscle layer (the intima) of a blood vessel wall is known as a cerebral or intracranial aneurysm. Flow diverters such the exceed flow diverter, silk flow diverter, and pipeline embolization device have been developed for the treatment of cerebral aneurysms. These endovascular devices are inserted inside the parent artery rather than the aneurysm sac. They profit from changed hemodynamics at the aneurysm/parent vascular junction, which gradually thromboses the aneurysm over time. Due to the ensuing inflammatory response, healing, and endothelial growth that causes the aneurysm to decrease, the parent artery lumen is typically preserved along with perforators and side branches. Wide neck and massive aneurysms, which were previously incurable, can be treated by flow diverters.

Growth of the global flow diverters market size is majorly driven by rise in the number of product launch and product approval for flow diverters and technological advancement in the healthcare sector. For instance, in February 2019, Medtronic Plc, medical device manufacturing company, announced the U.S. FDA (Food and Drug Administration) approval for an expanded indication of the Pipeline Flex embolization device. This device can be used for the treatment of patients with small or medium, wide-necked aneurysms. Moreover, in January 2020, MicroVention, Inc., (part of Terumo Corporation), medical equipment manufacturing company, received the U.S. FDA (Food and Drug Administration) Premarket Approval for its FRED to treat intracranial aneurysms. It utilizes self-expanding, woven nitinol mesh to re-direct blood flow and promote aneurysm occlusion.

In addition, rise in the prevalence of cerebral aneurysm and hypertension are anticipated to boost the market growth. For instance, according to national institute of Neurological Disorders and Stroke, it was reported that, all cerebral aneurysms have the potential to rupture and cause bleeding within the brain or surrounding area. Approximately 30,000 Americans per year suffer a brain aneurysm rupture. Hypertension is recognized as a major risk factor for the development, enlargement, and rupture of cerebral aneurysm. Hemodynamic stress and inflammation induced by high blood pressure could lead to arterial wall damage and dilation, resulting in the growth and rupture of cerebral aneurysm. Thus, rise in the prevalence of hypertension cause rise in the frequency of brain aneurysm. Thus, this factor cause rise in the demand for flow diverters. Hence, this factor is anticipated to boost the growth of flow diverters market.

On the other hand, the side effects associated with flow diverters and high cost of flow diverters anticipated to restrain the growth flow diverters market.  

Geriatric population is more susceptible to hypertension. Untreated hypertension can lead to serious complication like brain aneurysm. For instance, in August 2021, according to WHO (World Health Organization), it was reported that, more than 700 million people, worldwide are with untreated hypertension. The number of adults aged 30–79 years with hypertension has increased from 650 million to 1.28 billion in the last thirty years, according to the first comprehensive global analysis of trends in hypertension prevalence, detection, treatment and control, led by Imperial College London and WHO, nearly half these population did not know they had hypertension. Thus, rise in the geriatric population cause increase in the prevalence of hypertension. Hence, this factor is anticipated to drive the flow diverters market growth.

Flow Diverters Market Segmentation

The flow diverters market share is segmented into type, application, end user and region. On the basis of type the market is segmented into pipeline embolization device, silk flow diverter, surpass flow diverter, flow redirection endoluminal device and others. Others include electrical muscle stimulation, silk flow diverter and interferential current therapy (IC) P64, Silk & PED, PED & FRED. On the basis of application, market is bifurcated into cerebral aneurysms, multiple intracranial aneurysms and others. Multiple intracranial aneurysms segment is divided into ophthalmic artery, middle cerebral and posterior communicating artery. Others include large aneurysm, giant aneurysm, blister like, and fusiform aneurysm. On the basis of end user, the market is divided into hospitals and clinics and ambulatory surgical center. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Flow Diverters Market, By Type

The pipeline embolization device segment dominated the market in 2021, and is expected to continue this trend throughout the flow diverters market forecast period, owing to increase in the prevalence of cerebral aneurysm and rise in the number of product launch for pipeline embolization device.Pipeline embolization device is used to treat certain wide-necked intracranial aneurysms by diverting flow away from the aneurysm neck. Its application has been expanded to include both non-ruptured and ruptured cerebral aneurysms of various forms and causes in both the anterior and posterior circulations. 

Flow Diverters Market, By Application

The cerebral aneurysms segment dominated the market in 2021, and is expected to continue this trend throughout the forecast period, owing to increase in the prevalence of cerebral aneurysm and rise in the prevalence of hypertension. In addition, rise in the awareness among the people regarding minimally invasive surgery for the treatment of cerebral aneurysm and technological advancement in the healthcare sector are anticipated to boost the growth of the market. 

Flow Diverters Market, By End User

The hospitals and clinics segment dominated the market in 2021, and is expected to continue this trend throughout the forecast period, owing to increase in the number of hospitals and clinics and rise in the expenditure by government to develop healthcare infrastructure. Moreover, rise in geriatric population is anticipated to increase in the prevalence of hypertension and cerebral aneurysm which fuels the demand for flow diverters in hospitals and clinics for treatment. Thus, this factor is anticipated to drive the growth of the flow diverters market.

Flow Diverters Market, By Region

The North America market was dominant, in terms of revenue among other regions in 2021, owing to high presence of flow diverters industry who manufacture flow diverters and technological advancement in healthcare sector. On the other hand, Asia-Pacific was the second-largest contributor in the market in 2021, and is expected to register fastest CAGR during the forecast period, owing to increase in the initiative taken by government to develop healthcare infrastructure and rise in the number of geriatric populations.             

Some of the major companies that operate in the global flow diverters market include Acandis, BALT Extrusion SA, InspireMD, Johnson and Johnson, Medtronic, MicroPort Scientific Corporation, Microvention, Penumbra Inc., Phenox, Stryker Neurovascular.

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the flow diverters market analysis from 2021 to 2031 to identify the prevailing flow diverters market opportunity.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the flow diverters market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global flow diverters market trends, key players, market segments, application areas, and market growth strategies.

  Flow Diverters Market, by Type Report Highlights

Aspects	Details
Market Size By 2031	USD 1 billion
Growth Rate	CAGR of 15.3%
Forecast period	2021 - 2031
Report Pages	301
By Type	Pipeline embolization device Silk flow diverter Surpass flow diverter Flow redirection endoluminal device Others
By Application	Others Cerebral aneurysms Multiple Intracranial Aneurysms Location Ophthalmic artery Middle cerebral Posterior communicating artery
By End User	Hospital and clinics Ambulatory surgical center
By Region	North America  (U.S., Canada, Mexico) Europe  (Germany, France, UK, Italy, Spain, Rest Of Europe) Asia-Pacific  (China, Japan, India, Australia, South Korea, Rest Of Asia-Pacific) LAMEA  (Brazil, Saudi Arabia, South Africa, Rest Of LAMEA)
Key Market Players	Penumbra Inc., Johnson and Johnson, Acandis, Phenox, BALT Extrusion SA, MicroPort Scientific Corporation, Phenox GmbH, Stryker Neurovascular, Medtronic, Microvention

Analyst Review

Flow diverters are used for endovascular therapy of intracranial aneurysms. The flow diverters market is expected to growth during forecast period owing to, rise in the cases of cerebral or intracranial aneurysm, increase in geriatric population and rapid regulatory approvals from higher authorities.

Rise in adoption of key strategies such as collaboration, acquisition, agreement and partnership by key players of flow diverters fuels the growth of market. Moreover, rise in number of product launch and product approvals for flow diverters drives the market growth. For instance, in February 2019, Medtronic Plc, medical device manufacturing company, announced the U.S. FDA (Food and Drug Administration) approval for an expanded indication of the Pipeline Flex embolization device. This device can be used for the treatment of patients with small or medium, wide-necked aneurysms. Moreover, in January 2020, MicroVention, Inc., (part of Terumo Corporation), medical equipment manufacturing company, received the U.S. FDA (Food and Drug Administration) Premarket Approval for its FRED to treat intracranial aneurysms. It utilizes self-expanding, woven nitinol mesh to re-direct blood flow and promote aneurysm occlusion.

 

Author Name(s) : Linu Dash | Roshan Deshmukh

Related Tags

• Neurology
• Neurological Disorders
• Drug Delivery

^*Terms and Conditions Apply